News | May 18, 2025
Alivus Life Sciences reports Q4 FY25 PAT at Rs. 141.86 Cr
The company has posted net profit of Rs. 485.62 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 485.62 crores for the Financial Year ended March 31, 2025
Glenmark Life Sciences has reported total income of Rs. 515.41 crores during the period ended September 30, 2024
Glenmark Life Sciences has reported total income of Rs. 594.109 crores during the period ended June 30, 2024
Glenmark Life Sciences has reported total income of Rs. 574.49 crores during the period ended December 31, 2023
The company has reported total income of Rs. 547.33 crores during the period ended December 31, 2022
Subscribe To Our Newsletter & Stay Updated
